Intraoperative Radiotherapy (IORT): Delivery Methods and Clinical Applications
Intraoperative Radiotherapy (IORT) is a specialized technique where radiation is delivered directly to the tumor bed during surgery, immediately after the tumor has been removed. By treating the area while the surgical site is open, clinicians can target malignant tissues with high precision while minimizing exposure to surrounding healthy organs.
Over the decades, IORT has evolved from basic X-ray applications to sophisticated mobile technologies. Today, several distinct delivery methods are used, each varying in energy levels, penetration depth, and logistical requirements.
Key Facts
- Electron IORT is highly precise, treating depths up to 4 cm in just 1–3 minutes.
- Low-energy IORT (50 kV) offers higher relative biological effectiveness (RBE) and requires no special room shielding.
- HDR-IORT utilizes high-dose-rate brachytherapy and is often used for complex anatomic surfaces.
- X-ray IORT (Orthovoltage) is largely obsolete due to poor dose uniformity and risks to bony structures.
- Mobile technology, such as the Mobetron, has significantly increased the accessibility of electron IORT.
Electron IORT
The modern era of IORT began in the mid-1960s with the introduction of electron beams. Initially, this required transporting patients from the operating room (OR) to the radiation department, a process fraught with logistical challenges. To solve this, some hospitals built shielded ORs with installed linear accelerators, though the high cost limited this approach.
A major breakthrough occurred in 1997 with the development of mobile linear accelerators, including the self-shielded Mobetron (IntraOp Corporation, US) and the unshielded Novac (Liac–SIT, Italy). These devices allow the radiation to be brought directly to the patient.
Electron IORT uses energies between 3 MeV and 12 MeV, allowing for carefully controlled penetration depths of up to 4 cm over areas as large as 300 cm². Because the dose is delivered rapidly (1–3 minutes) and uniformly, it has become a preferred method, with over 75,000 patients treated to date.
[ไม่มีภาพประกอบ]
X-ray IORT
Before high-energy electrons were available, practitioners used superficial X-rays (75–125 kV) and orthovoltage X-rays (up to 300 kV), primarily for abdominal malignancies. For much of its history, this method was used for palliation—relieving symptoms rather than curing the disease.
In the 1980s, some centers attempted to use orthovoltage units in lightly shielded ORs as a low-cost alternative to electron IORT. However, this method suffered from poor dose uniformity and a lack of a pre-defined depth limit, meaning radiation continued to deposit into underlying structures and could damage bone. Consequently, fewer than 1,000 patients have been treated with this method, and it is rarely offered today.
High-Dose-Rate Brachytherapy (HDR-IORT)
Developed in the late 1980s, HDR-IORT combines the benefits of brachytherapy—the placement of radioactive sources directly into or near the tissue—with the surgical access of IORT. This method is cost-effective for centers that already own HDR systems that can be transported to the OR.
HDR-IORT is particularly useful for treating large or convoluted anatomic surfaces. However, it has significant drawbacks: it requires a shielded room, has a very limited penetration depth (typically 0.5 cm to 1 cm), and requires longer treatment times (40 minutes or more). These factors lead to increased anesthesia time and greater blood loss. Approximately 2,000 patients have received HDR-IORT, primarily for gynecologic, head and neck, and colorectal cancers.
Low-energy IORT (50 kV)
Low-energy IORT, such as the Intrabeam system (Carl Zeiss AG, Germany), uses a miniature mobile X-ray source that emits radiation at a maximum of 50 kV in an isotropic (uniform in all directions) distribution. This method is characterized by a higher Relative Biological Effectiveness (RBE), meaning the soft X-rays are more effective at killing tumor cells than high-energy X-rays or gamma rays.
Because the radiation has a very limited range, standard hospital walls are sufficient to stop scatter, eliminating the need for expensive radiation shielding in the OR. A prominent application is Targeted Intra-operative Radiotherapy (TARGIT-IORT) for breast cancer. Clinical trials published in the British Medical Journal indicate that TARGIT-IORT is as effective as whole-breast external beam radiotherapy in controlling cancer and may reduce deaths from other causes.
[ไม่มีภาพประกอบ]
Comparison of IORT Delivery Methods
| Method | Energy/Type | Penetration Depth | Treatment Time | Shielding Required |
|---|---|---|---|---|
| Electron IORT | 3–12 MeV | Up to 4 cm | 1–3 minutes | Yes (Mobile or Room) |
| X-ray (Orthovoltage) | Up to 300 kV | Poorly defined | Variable | Light shielding |
| HDR-IORT | Brachytherapy | 0.5–1 cm | 40+ minutes | Yes (Room) |
| Low-energy IORT | Max 50 kV | Limited range | Variable | No (Standard walls) |
Frequently Asked Questions
What is the main advantage of Electron IORT over X-ray IORT?
Electron IORT provides a very uniform dose and allows clinicians to carefully control the depth of radiation penetration, whereas X-ray IORT has poor dose uniformity and can damage underlying bony structures.
Why is low-energy IORT more accessible for hospitals?
Low-energy IORT (50 kV) has a limited radiation range, meaning conventional hospital walls are sufficient to stop radiation scatter. This removes the need for costly specialized radiation shielding in the operating room.
How does HDR-IORT differ from other IORT methods in terms of OR time?
HDR-IORT requires significantly more time in the operating room—typically 40 minutes or longer—which leads to increased anesthesia requirements and greater blood loss compared to the rapid delivery of electron IORT.
What is TARGIT-IORT and is it effective?
TARGIT-IORT is a low-energy IORT technique used for breast cancer. Research published in the British Medical Journal confirms it is as effective as whole breast external beam radiotherapy for cancer control.
What is Relative Biological Effectiveness (RBE) in the context of IORT?
RBE refers to the ability of a specific type of radiation to cause biological damage. Low-energy X-rays have a higher RBE on tumor cells compared to the high-energy X-rays or gamma rays used in other systems.